Premium Information is available for this item - Upgrade for $1 a day
6505-01-371-7815
Theophylline Extended-Release Tablets
6505013717815 013717815 NDC00258-3583-10
January 2023
3
Marketplace 6505-01-371-7815
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-371-7815 5+ Documents (More...)
6505-01-371-7815 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-371-7815
Day 6505-01-371-7815 RQST NE Related Documents 6505-01-371-7815 5+ Documents ( More... ) https//www.nsnlookup.com
Documents 6505-01-093-9477 5+ Documents ( More https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-371-7815
/fsc-6505/us 6505-01-093-9477 6505-99-212-8295 6505- 01-215-4389 093-9477 6505-01-124-5380 6505-01-371-7815
6505-01-215-4389 Theophylline Extended-Release Tablets NDC00258-3583-10 https//www.nsnlookup.com
/fsg-65/fsc-6505/us 6505-01-215-4389 Tablets NDC00258-3583-10 Extended-Release Tablets https//www.nsnlookup.com
Theophylline Extended-Release Tablets https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-371-7815
Reference RNCC 6 RNVC 9 DAC 9 NATO Stock Numbers Related to 6505-99-212-8295 6505-01-124-5380 6505-01-371-7815
Documents 6505-01-070-0821 5+ Documents ( More... https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-371-7815
NDC00258-3583-10 6505-01-215-4389 Theophylline Extended-Release Tablets Theophylline Extended-Release
Restrictions 6505-01-371-7815
6505-01-371-7815 is a Theophylline Extended-Release Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-371-7815
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-371-7815
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-371-7815
- Part Number
- Manufacturer
- Status
- NDC00258-3583-10
- Manufacturer
- 65050 - Forest Pharmaceuticals Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-371-7815
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 200.000 Milligrams Theophylline Active Ingredient
- Long Action Method [AKJF]
- Extended Release
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
Management Data 6505-01-371-7815
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Feb 1993
- Veterans Administration (VA)
- BT
- Subscribe
- 1
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Ea
- 00000001000EA
- K
NATO Stock Numbers Related to 6505-01-371-7815
Freight Information 6505-01-371-7815
6505-01-371-7815 has freight characteristics.. 6505-01-371-7815 has a variance between NMFC and UFC when transported by rail and the description should be consulted.